These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Walking and weakness in children: a narrative review of gait and functional ambulation in paediatric neuromuscular disease. Kennedy RA; Carroll K; McGinley JL; Paterson KL J Foot Ankle Res; 2020 Mar; 13(1):10. PubMed ID: 32122377 [TBL] [Abstract][Full Text] [Related]
28. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy. Alman BA; Raza SN; Biggar WD J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment. Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868 [TBL] [Abstract][Full Text] [Related]
30. Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database. Joseph S; Wang C; Bushby K; Guglieri M; Horrocks I; Straub V; Ahmed SF; Wong SC; JAMA Neurol; 2019 Jun; 76(6):701-709. PubMed ID: 30855644 [TBL] [Abstract][Full Text] [Related]
31. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy. Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398 [TBL] [Abstract][Full Text] [Related]
32. Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance. Nair KS; Lott DJ; Forbes SC; Barnard AM; Willcocks RJ; Senesac CR; Daniels MJ; Harrington AT; Tennekoon GI; Zilke K; Finanger EL; Finkel RS; Rooney WD; Walter GA; Vandenborne K J Neuromuscul Dis; 2022; 9(3):423-436. PubMed ID: 35466946 [TBL] [Abstract][Full Text] [Related]
33. Normalized grip strength is a sensitive outcome measure through all stages of Duchenne muscular dystrophy. Hogrel JY; Decostre V; Ledoux I; de Antonio M; Niks EH; de Groot I; Straub V; Muntoni F; Ricotti V; Voit T; Seferian A; Gidaro T; Servais L J Neurol; 2020 Jul; 267(7):2022-2028. PubMed ID: 32206900 [TBL] [Abstract][Full Text] [Related]
37. Skeletal disproportion in glucocorticoid-treated boys with Duchenne muscular dystrophy. Kao KT; Joseph S; Capaldi N; Brown S; Di Marco M; Dunne J; Horrocks I; Shepherd S; Ahmed SF; Wong SC Eur J Pediatr; 2019 May; 178(5):633-640. PubMed ID: 30762116 [TBL] [Abstract][Full Text] [Related]
38. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study. McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930 [TBL] [Abstract][Full Text] [Related]
39. Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy. Arteaga D; Donnelly T; Crum K; Markham L; Killian M; Burnette WB; Soslow J; Buchowski MS J Neuromuscul Dis; 2020; 7(3):331-342. PubMed ID: 32417792 [TBL] [Abstract][Full Text] [Related]
40. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study. Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]